Preview Mode Links will not work in preview mode
Welcome to the Empowered Patient Podcast with Karen Jagoda.  This show offers a glimpse into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the evolving dynamics in the medical and healthcare landscape. One focus is on how providers, pharmaceutical companies, and payers are empowering patients.  In addition, conversations often focus on how technology is empowering providers, care facilities, pharmaceutical companies, and payers to improve patient outcomes and reduce friction across the healthcare landscape.  Popular Topics Include: Virtual and digital health Use of AI, ML, and robots for clinical and administrative purposes  Value-based healthcare  Precision and stratified medicine Next-generation immuno, cell, and gene therapies Vaccines for infectious diseases and oncology Biomarkers and diagnostics Rare diseases MedTech and medical devices Clinical trials  Population health Chronic conditions l Clinician and staff burnout Smart hospitals The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors.

Apr 15, 2019

William Annett, CEO, OncoCyte discusses the exciting work the company is doing in the liquid biopsy space.  They have developed DetermaVu™ a liquid biopsy test for lung cancer, which studies show has the potential to detect the absence of cancer by analyzing a simple blood sample.  This technique allows individuals to potentially avoid risky, expensive lung biopsies.  The company recently announced promising R&D validation data and is planning to make the test available to patients and physicians later this year.

@OncocyteLbx

#LiquidBiopsy  #LungCancer #DetermaVu

OncoCyte.com